Quick Takeaways
- Robert E. Conway has 2 issuer positions tracked on this page.
- Estimated disclosed ownership value: $125,000.
- Recent insider filing activity is available below.
- Info
- Insider Ownership
Insider Trading & Ownership of Robert E. Conway
- Location
- Broomfield, CO
- Summary
- The estimated net worth of Robert E. Conway is at least $125,000 dollars as of 20 May 2024. Robert E. Conway is the Director, Chairman of the Board of ARCA biopharma, Inc. and owns shares of Oruka Therapeutics, Inc. (ORKA) stock worth about $125K.
- Signature
- /s/ James Paul Rickey, attorney-in-fact
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow Robert E. Conway and return when a new Insider Trading filing appears.
This tracks SEC filing changes for this page using existing product update flows.
What Changed
- Largest disclosed position: ARCA biopharma, Inc. ($125,000).
- Past-year value change for that position: .
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Official SEC Source
Filed on Form 4
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
See Original FilingOwnership of Robert E. Conway
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| ORKA | ARCA biopharma, Inc. | Director, Chairman of the Board | $125,000 | 30 Jan 2024 | ||
| ALPN | ALPINE IMMUNE SCIENCES, INC. | Director | $0 | 20 May 2024 |
Insider Transactions Reported by Robert E. Conway:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.